The mechanisms by which oncogenic mutations and anatomical locations work together to influence the immune environment within tumors are not well understood. In this issue of Immunity, Ross et al. show that H3.3K27M diffuse midline gliomas (DMGs) are enriched with disease-associated myeloid cells (DAMs). Myeloid-targeted strategies reprogram DAMs to a homeostatic state, reduce myeloid infiltration into tumors, and prolong survival.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.immuni.2024.10.007 | DOI Listing |
Publication Analysis
Top Keywords
navigating mutation
4
mutation maze
4
maze oncogenic
4
oncogenic driver's
4
driver's guide
4
guide macrophage
4
macrophage reprogramming
4
reprogramming mechanisms
4
mechanisms oncogenic
4
oncogenic mutations
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!